Journal Article

Pre-infection liver function is associated with all-cause mortality among hemodialysis patients with SARS-CoV-2 Omicron variant infection

Zhang, Quanchao, Tang, Bingshuang, Wang, Liao, Jiang, Lili, Chen, Hongwei, He, Jin, Liao, Shengli, Lu, Caibao, Li, Moqi, Wu, Shaofa, Wu, Zhifen, Nie, Ling, He, Wenchang, Li, Jie, Zhao, Jinghong, Wang, Yiqin, Wang, Han, Yang, Bingfeng

2024

Overview

There is ample evidence to suggest that patients infected with SARS-CoV-2 Omicron variant may experience liver dysfunction. However, the impact of pre-infection liver function on postinfection mortality rates remains inadequately researched. Data from 847 hemodialysis (HD) patients, diagnosed with Omicron across six HD centers between December 2022 and February 2023, were analyzed. Initial liver function assessments were conducted, following which patients were monitored for mortality outcomes. The stepwise multivariable Cox regression analysis and receiver operating characteristic (ROC) curves were utilized to identify the predictors of mortality. From the total, 98 patients (11.6%) succumbed, with a majority (80/98) within a month postinfection. The deceased patients were observed to be mostly older males with an increased prevalence of diabetes and tumors, signifying higher AST and C-reactive protein levels. These patients also exhibited lower hemoglobin, albumin, and prealbumin levels. An elevated AST [per 1 IU increment; HR 1.04 (95% CI 1-1.04),  = 0.026], AST/ALT ratio [per 1 increment; HR 1.52 (95% CI 1.27-2.36),  = 0.004], and reduced prealbumin [per 10 mg/L increment; HR 0.93 (95% CI 0.9-0.96),  < 0.001] were discovered to be independent indicators of an increased mortality risk. Notably, AST, AST/ALT ratio, and prealbumin proved significant predictors of mortality (AUC values were 0.59, 0.65, and 0.79 respectively). This study underscores that pre-infection liver function, specifically AST, AST/ALT ratio, and prealbumin levels, substantially influence the mortality rates in HD patients following Omicron infection. Therefore, careful consideration of these liver function parameters could guide superior patient management strategies and potentially decrease mortality rates within this at-risk population.

• Publisher: Taylor & Francis Ltd,Taylor & Francis,Taylor & Francis Group
• Subject: Aged / C-reactive protein / COVID-19 - complications / COVID-19 - mortality / Diabetes mellitus / Female / Hemodialysis / Hemodialysis and Peritoneal Dialysis / Hemoglobin / Humans / Infections / Kidney Failure, Chronic - complications / Kidney Failure, Chronic - mortality / Kidney Failure, Chronic - therapy / Liver / Liver diseases / Liver Diseases - mortality / Liver Diseases - virology / liver function / Liver Function Tests / Male / Middle Aged / Mortality / Omicron / Renal Dialysis / Retrospective Studies / SARS-CoV-2 / Severe acute respiratory syndrome coronavirus 2